News

The acquisition includes MediSolution’s healthcare-specific product suites including the electronic health record systems, a patient management suite, clinical department systems, lab information systems, and public health and community

This reduction was not statistically significant (p=0.216; HR 0.92) compared to patients receiving placebo in addition to current standard of care. Results of the main secondary endpoint of

Pursuant to the agreement, both the companies will work together to develop a superior breast cancer prognostic test using Health Discovery Corporation’s (HDC’s) support vector machine technology in

These results pertaining to overall survival, a secondary endpoint, are an update to the previously reported results for progression-free survival (PFS), the study’s primary endpoint, which were announced

Dr Tamura has recently retired as representative director, executive vice president and chief science officer of Astellas Pharma. Dr Tamura has received a PhD degree from the University

The CE mark expands Hoana’s patient safety reach to include more than 30 countries in the EU. Hoana’s technology is said to transform any hospital bed into a

Under the agreement, JAC will offer a variety of products including specialized cabinets for controlled drugs, night use on wards, and in environments where access to medicines needs

According to the company, the 2D cardiac performance analysis is a speckle tracking based analysis tool which can analyze 2D data from various ultrasound machines. The user can

Intelence is said to be the first new non-nucleoside reverse transcriptase inhibitor to be introduced in approximately 10 years. Also known as TMC125, Intelence will be marketed in